All TARDBP mutation carriers identified in this study presented with probable ALS according to El Escorial criteria in the absence of atypical clinical signs, in agreement with the previous reports on TARDBP mutation carriers. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.